目的探讨缩宫素联合黄芪注射液治疗协调性子宫收缩乏力的疗效,为治疗协调性子宫收缩乏力提供用药依据。方法将98例协调性子宫收缩乏力患者随机分为观察组与对照组各49例,观察组接受缩宫素联合黄芪注射液治疗,对照组仅接受缩宫素治疗,对比分析两组疗效。结果①观察组疗效显著优于对照组,差异有统计学意义(P<0.05)。②两组患者不良反应发生率相比差异无统计学意义(P>0.05)。结论缩宫素联合黄芪注射液是治疗协调性子宫收缩乏力的有效方法之一,值得临床应用与推广。 Objective To explore the curative effect of oxytocin combined with Astragalus injection on patients with coordinated uterine atony and to provide basis for the treatment of uterine atony. Methods 98 patients with coordinated uterine atony were randomly divided into observation group and control group, 49 cases in each group. The observation group received oxytocin combined with astragalus injection, while the control group received only oxytocin treatment. The curative effect was compared between the two groups. Results ① The observation group was significantly better than the control group, the difference was statistically significant (P <0.05). ② There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion oxytocin combined with Astragalus injection is an effective method for the treatment of uterine atresia coordination, it is worth clinical application and promotion.